CDC7 inhibition can drive senescence in several cell types67,68 and CDC7 inhibition in combination with agents that eliminate senescent cells was shown to have a very profound anti-tumor activity specifically in p53 mutated liver cancer models, suggesting a possible strategy to target these very aggressive tumors for which there is still a major unmet medical need.67 This evidence concerns the gene TP53 and liver cancer.